The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Written by
in
Clinical Trials, Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, LSD (Lysergic Acid Diethylamide), Lykos Therapeutics, Mental Health and Disorders, Post-Traumatic Stress Disorder, Psilocybin Mushrooms, Psychedelic and Hallucinogenic Drugs, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Therapy and Rehabilitation, Veterans